Response to: 'Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis'' by Xu

被引：0
作者：
Mok, Chi Chiu [1 ]
机构：
[1] Tuen Mun Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷 / 12期
关键词：
lupus nephritis; therapeutics; lupus erythematosus; systemic; POSTERIOR REVERSIBLE ENCEPHALOPATHY; ANTIPHOSPHOLIPID SYNDROME; ERYTHEMATOSUS;
D O I：
10.1136/annrheumdis-2020-219087
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 10 条
[1]   Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study [J].
Damrongpipatkul, Usanee ;
Oranratanachai, Kanokporn ;
Kasitanon, Nuntana ;
Wuttiplakorn, Salita ;
Louthrenoo, Worawit .
CLINICAL RHEUMATOLOGY, 2018, 37 (03) :691-702
[2]   Posterior reversible encephalopathy syndrome as a neuropsychiatric manifestation of systemic lupus erythematosus [J].
Ho, C. M. ;
Mok, C. C. .
HONG KONG MEDICAL JOURNAL, 2019, 25 (05) :410-412
[3]   Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome [J].
Jung, S. M. ;
Moon, S-J ;
Kwok, S-K ;
Ju, J. H. ;
Park, K-S ;
Park, S-H ;
Kim, H-Y .
LUPUS, 2013, 22 (09) :885-891
[4]   Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus [J].
Kotzen, Elizabeth S. ;
Roy, Sanjeet ;
Jain, Koyal .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (05) :376-386
[5]   Clinical Features and Outcomes of Posterior Reversible Encephalopathy Syndrome in Patients With Systemic Lupus Erythematosus [J].
Lai, Chien-Chih ;
Chen, Wei-Sheng ;
Chang, Yu-Sheng ;
Wang, Shu-Hung ;
Huang, Chun-Jui ;
Guo, Wan-Yuo ;
Yang, Wu-Chang ;
Huang, De-Feng .
ARTHRITIS CARE & RESEARCH, 2013, 65 (11) :1766-1774
[6]   International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J].
Miyakis, S ;
Lockshin, MD ;
Atsumi, T ;
Branch, DW ;
Brey, RL ;
Cervera, R ;
Derksen, RHWM ;
De Groot, PG ;
Koike, T ;
Meroni, PL ;
Reber, G ;
Shoenfeld, Y ;
Tincani, A ;
Vlachoyiannopoulos, PG ;
Krilis, SA .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :295-306
[7]   Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis [J].
Mok, Chi Chiu ;
Ho, Ling Yin ;
Ying, Shirley King Yee ;
Leung, Man Chi ;
To, Chi Hung ;
Ng, Woon Leung .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (08) :1070-1076
[8]   Prevalence of the Antiphospholipid Syndrome and Its Effect on Survival in 679 Chinese Patients With Systemic Lupus Erythematosus A Cohort Study [J].
Mok, Chi Chiu ;
Chan, Pak To ;
Ho, Ling Yin ;
Yu, Ka Lung ;
To, Chi Hung .
MEDICINE, 2013, 92 (04) :217-222
[9]   A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis [J].
Rovin, Brad H. ;
Solomons, Neil ;
Pendergraft, William F., III ;
Dooley, Mary Anne ;
Tumlin, James ;
Romero-Diaz, Juanita ;
Lysenko, Lidia ;
Navarra, Sandra V. ;
Huizinga, Robert B. .
KIDNEY INTERNATIONAL, 2019, 95 (01) :219-231
[10]   Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis' [J].
Xu, Chuanhui .
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12)
1